Proteomic screening and analysis of plasma secrete protein markers in patients with post-stroke depression

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200060072

Enrollment

Unknown

Registered

2022-05-17

Start date

2022-09-01

Completion date

Unknown

Last updated

2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke depression

Interventions

Gold Standard:Diagnostic criteria of stroke, post-stroke depression and depression

Index test:Exosome

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with post-stroke depression according to clinical diagnosis; 2. Patients with complete clinical data; 3. Patients who agree to cooperate with and assist the medical staff of our hospital to complete the investigation and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumors or severe organ dysfunction; 2. Patients with infectious diseases; 3. Patients with poor treatment compliance; 4. Patients with physical disabilities; 5. Patients who withdraw from the experiment.

Design outcomes

Primary

Measure	Time frame
exosome;	—

Countries

China

Contacts

Public ContactYue Xuejing

Xinxiang Medical University

jing04001825@126.com+86 13938736494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026